Turn Therapeutics announces presentations at TD Cowen and Oppenheimer healthcare conferences

Turn Therapeutics Inc.

CEO Brad Burnam to present at 46th Annual TD Cowen Healthcare Conference in Boston on March 2, 2026.
Also presenting virtually at 36th Annual Oppenheimer Healthcare Life Sciences Conference on February 25, 2026.
Company to provide update on Phase 2 trial of GX-03 for moderate-to-severe atopic dermatitis.
Updated investor presentation posted on company website on February 9, 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.